NABCYTE
Live / Applied — Statement of use — final refusal mailed (as of 20 Jan 2026)
What this means for you
Not registered yet, but its 09 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97788077
- Mark type
- Stylized text
- Filed
- 09 Feb 2023
- Published for opposition
- 17 Oct 2023
- Attorney of record
- William M. Bryner
Goods and services
- Class 001 — Chemicals: Assays for research purposes; assays for clinical or medical laboratory use; assays for detecting antibodies in clinical trials and pharmaceutical research for research purposes; assays for detecting the presence of antibodies for research purposes in the fields of pharmaceutical testing, biotechnology, medical research, and clinical trials for medical research
- Class 005 — Pharmaceuticals: Medical diagnostic assays for detecting the presence of antibodies for medical purposes; diagnostic kits for medical use comprised of medical diagnostic reagents and assays for testing for the presence of antibodies
Owner
- Laboratory Corporation of America Holdings, Burlington, NC, US
- Laboratory Corporation of America Holdings, Burlington, NC, US
Prosecution history
- 20 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 20 Jan 2026 — FINAL REFUSAL E-MAILED
- 20 Jan 2026 — SU - FINAL REFUSAL - WRITTEN
- 22 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Dec 2025 — ASSIGNED TO LIE
- 12 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 29 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 May 2025 — USE AMENDMENT FILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 May 2025 — SOU EXTENSION 3 GRANTED